Jesup & Lamont Announces Presenting LifeTech Companies and Former FDA Commissioner at Annual Growth Stock & National Sales Confe
13 Juillet 2009 - 2:30PM
PR Newswire (US)
NEW YORK, July 13 /PRNewswire-FirstCall/ -- Jesup & Lamont,
Inc., (AMEX: JLI), a full-service boutique brokerage and investment
banking firm serving retail and institutional clients, today
announced the LifeTech Capital Group companies presenting at its
2009 Growth Stock & National Sales Conference to be held at the
Waldorf Astoria Boca Beach Club on July 30th, 2009 in Boca Raton,
Florida. In addition, former FDA Commissioner Dr. Lester M.
Crawford D.V.M., Ph.D., will be the keynote speaker for the event.
"As large pharmaceutical companies continue to struggle with patent
expirations, pricing pressures, R&D cuts and changes to the
U.S. healthcare system, we believe smaller biotech companies
represent an exciting source of value-creation for investors," says
Stephen M. Dunn, Managing Director of Life Sciences Research at
LifeTech Capital Group. "With the government's recent demands for
comparative effectiveness of drugs, there is a corresponding
increase in demand for companies with novel, breakthrough
approaches. We're pleased to have such a diversified group of
innovative biotech companies presenting at our conference." Some of
the companies presenting on July 30th include Peregrine
Pharmaceuticals (NASDAQ:PPHM), Cytori Therapeutics (NASDAQ:CYTX),
NovaBay Pharmaceuticals (AMEX:NBY), Nabi Biopharmaceuticals
(NASDAQ:NABI), OXiGENE Inc. (NASDAQ:OXGN), Access Pharmaceuticals
(OTC:ACCP) (BULLETIN BOARD: ACCP) , Echo Therapeutics (OTC:ECTE)
(BULLETIN BOARD: ECTE) , Raptor Pharmaceuticals (OTC Bulletin
Board: RPTP), Neoprobe Corp. (OTC:NEOP) (BULLETIN BOARD: NEOP) and
Oxygen Biotherapeutics (OTC:OXBO) (BULLETIN BOARD: OXBO) . Jesup's
annual conference provides its clients a distinctive forum in which
to visit with and hear presentations from unique growth companies
in the life sciences, healthcare, aerospace and transportation
industries. The conference commences with Life Science industry and
investor panels on Wednesday July 29th with Company presentations
on Thursday July 30th, followed by Investment Products
presentations on August 1st and 2nd. Last year's conference brought
together hundreds of institutional and retail investors in an
intimate format. For more information or registration to present or
attend, contact your Jesup salesperson, Donald A. Wojnowski at or
Tammy Kraus at . You can also register online at
http://www.jesuplamontconferences.com/. About Jesup & Lamont,
Inc. Established in 1877, Jesup & Lamont, Inc. has an extensive
history on Wall Street, with its origins encompassing such
successes as providing brokerage services to Standard Oil and
raising capital for the construction of Rockefeller Center. Jesup
& Lamont, through its two wholly owned brokerage subsidiaries,
offers full service broker-dealer and registered investment
advisory services through its approximately 150 retail brokers in
over 20 locations including offices in New York, San Francisco,
Boston, Boca Raton, Chicago, Fort Lauderdale and Orlando. The
Company's Jesup & Lamont Securities Corporation subsidiary also
publishes proprietary research on several industries including
Aerospace/Defense, Alternative Energy and Life Sciences/Healthcare
and offers comprehensive investment banking services.
Forward-Looking Statement Disclaimer This press release contains
"forward looking statements" within the meaning of the Private
Securities Litigation Reform Act of 1995. Such forward-looking
statements involve known and unknown risk, uncertainties or other
factors which may cause actual results, performance or achievements
of the Company to be materially different from any future results,
performance or achievements expressed or implied by such
forward-looking statements. Factors that might cause such a
difference include, without limitation, fluctuations in the volume
of transactional services provided by the Company, competition with
respect to financial services commission rates, the effect of
general economic and market conditions, factors affecting the
securities brokerage industry as well as other risks and
uncertainties detailed from time to time in the Company's
Securities and Exchange Commission filings. The Company undertakes
no obligation to revise or update any forward-looking statement.
DATASOURCE: Jesup & Lamont, Inc. CONTACT: Donald A. Wojnowski,
President of Jesup & Lamont, Inc., +1-212-307-2660, Web Site:
http://www.jesuplamontconferences.com/
Copyright